ES2146574T3 - Secuencias de nucleotidos y polipeptidos, en particular del virus del colera del cerdo. - Google Patents

Secuencias de nucleotidos y polipeptidos, en particular del virus del colera del cerdo.

Info

Publication number
ES2146574T3
ES2146574T3 ES90910520T ES90910520T ES2146574T3 ES 2146574 T3 ES2146574 T3 ES 2146574T3 ES 90910520 T ES90910520 T ES 90910520T ES 90910520 T ES90910520 T ES 90910520T ES 2146574 T3 ES2146574 T3 ES 2146574T3
Authority
ES
Spain
Prior art keywords
infection
polypeptides
sequences
nucleotide
chole
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Expired - Lifetime
Application number
ES90910520T
Other languages
English (en)
Other versions
ES2146574T5 (es
Inventor
Robertus Jacobus Mari Moormann
Gert Wensvoort
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Centraal Diergeneeskundig Instituut
Original Assignee
Centraal Diergeneeskundig Instituut
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Family has litigation
First worldwide family litigation filed litigation Critical https://patents.darts-ip.com/?family=19854928&utm_source=google_patent&utm_medium=platform_link&utm_campaign=public_patent_search&patent=ES2146574(T3) "Global patent litigation dataset” by Darts-ip is licensed under a Creative Commons Attribution 4.0 International License.
Application filed by Centraal Diergeneeskundig Instituut filed Critical Centraal Diergeneeskundig Instituut
Publication of ES2146574T3 publication Critical patent/ES2146574T3/es
Application granted granted Critical
Publication of ES2146574T5 publication Critical patent/ES2146574T5/es
Anticipated expiration legal-status Critical
Expired - Lifetime legal-status Critical Current

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N15/00—Mutation or genetic engineering; DNA or RNA concerning genetic engineering, vectors, e.g. plasmids, or their isolation, preparation or purification; Use of hosts therefor
    • C12N15/09—Recombinant DNA-technology
    • C12N15/11—DNA or RNA fragments; Modified forms thereof; Non-coding nucleic acids having a biological activity
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N15/00—Mutation or genetic engineering; DNA or RNA concerning genetic engineering, vectors, e.g. plasmids, or their isolation, preparation or purification; Use of hosts therefor
    • C12N15/09—Recombinant DNA-technology
    • C12N15/63—Introduction of foreign genetic material using vectors; Vectors; Use of hosts therefor; Regulation of expression
    • C12N15/79—Vectors or expression systems specially adapted for eukaryotic hosts
    • C12N15/85—Vectors or expression systems specially adapted for eukaryotic hosts for animal cells
    • C12N15/8509—Vectors or expression systems specially adapted for eukaryotic hosts for animal cells for producing genetically modified animals, e.g. transgenic
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/12—Antivirals
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • C07K14/005—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from viruses
    • A—HUMAN NECESSITIES
    • A01—AGRICULTURE; FORESTRY; ANIMAL HUSBANDRY; HUNTING; TRAPPING; FISHING
    • A01K—ANIMAL HUSBANDRY; AVICULTURE; APICULTURE; PISCICULTURE; FISHING; REARING OR BREEDING ANIMALS, NOT OTHERWISE PROVIDED FOR; NEW BREEDS OF ANIMALS
    • A01K2217/00—Genetically modified animals
    • A01K2217/05—Animals comprising random inserted nucleic acids (transgenic)
    • A—HUMAN NECESSITIES
    • A01—AGRICULTURE; FORESTRY; ANIMAL HUSBANDRY; HUNTING; TRAPPING; FISHING
    • A01K—ANIMAL HUSBANDRY; AVICULTURE; APICULTURE; PISCICULTURE; FISHING; REARING OR BREEDING ANIMALS, NOT OTHERWISE PROVIDED FOR; NEW BREEDS OF ANIMALS
    • A01K2267/00—Animals characterised by purpose
    • A01K2267/02—Animal zootechnically ameliorated
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00—Medicinal preparations containing antigens or antibodies
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N2770/00—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA ssRNA viruses positive-sense
    • C12N2770/00011—Details
    • C12N2770/24011—Flaviviridae
    • C12N2770/24111—Flavivirus, e.g. yellow fever virus, dengue, JEV
    • C12N2770/24122—New viral proteins or individual genes, new structural or functional aspects of known viral proteins or genes

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Genetics & Genomics (AREA)
  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Engineering & Computer Science (AREA)
  • Biomedical Technology (AREA)
  • Wood Science & Technology (AREA)
  • Biotechnology (AREA)
  • Zoology (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Molecular Biology (AREA)
  • General Engineering & Computer Science (AREA)
  • General Health & Medical Sciences (AREA)
  • Biochemistry (AREA)
  • Biophysics (AREA)
  • Plant Pathology (AREA)
  • Medicinal Chemistry (AREA)
  • Physics & Mathematics (AREA)
  • Virology (AREA)
  • Microbiology (AREA)
  • Veterinary Medicine (AREA)
  • General Chemical & Material Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Animal Behavior & Ethology (AREA)
  • Public Health (AREA)
  • Communicable Diseases (AREA)
  • Oncology (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Micro-Organisms Or Cultivation Processes Thereof (AREA)
  • Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
  • Peptides Or Proteins (AREA)
  • Measuring Or Testing Involving Enzymes Or Micro-Organisms (AREA)
  • Preparation Of Compounds By Using Micro-Organisms (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)

Abstract

UN METODO PARA PROTEGER UN SUJETO, EN PARTICULAR UN ANIMAL DOMESTICO, CONTRA UNA INFECCION MICROBIANA COMPRENDE EL USO DE UNA COMBINACION DE UNA SECUENCIA NUCLEOTIDA CODIFICANDO UN ANTIGENO RELACIONADO CON LA INFECCION Y UNA SECUENCIA NUCLEOTIDA DE TRANSFERENCIA DE INTERRUPCION. UN METODO PARA CONSTRUIR UN ANIMAL TRANSGENICO QUE ES RESISTENTE AL ORGANISMO INFECCIOSO COMPRENDE EL INCORPORAR UNA SECUENCIA NUCLEOTIDA RELACIONADA CON LA INFECCION EN EL GENOMA DEL ANIMAL. EL METODO ES ESPECIALMENTE UTIL PARA PROPORCIONAR PROTECCION CONTRA INFECCIONES DE VIRUS DE PESTES TALES COMO COLERA DE LOS CERDOS (FIEBRE PORCINA). TAMBIEN SE DESCRIBEN SECUENCIAS NUCLEOTIDAS Y SUS CONSTRUCTORES DE VECTOR, Y POLIPEPTIDOS UTILES PARA PRODUCIR VACUNAS Y PARA DIAGNOSIS. SE DESCRIBE UN METODO DE DIAGNOSTICO QUE DIFERENCIA ANIMALES INFECTADOS Y ANIMALES VACUNADOS.
ES90910520T 1989-06-29 1990-06-29 Secuencias de nucleotidos y polipeptidos, en particular del virus del colera del cerdo. Expired - Lifetime ES2146574T5 (es)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
NL8901651 1989-06-29
NL8901651A NL8901651A (nl) 1989-06-29 1989-06-29 Vaccin tegen pestivirusinfecties, zoals varkenspest; daarvoor bruikbare nucleotidesequenties en polypeptiden.

Publications (2)

Publication Number Publication Date
ES2146574T3 true ES2146574T3 (es) 2000-08-16
ES2146574T5 ES2146574T5 (es) 2005-10-16

Family

ID=19854928

Family Applications (1)

Application Number Title Priority Date Filing Date
ES90910520T Expired - Lifetime ES2146574T5 (es) 1989-06-29 1990-06-29 Secuencias de nucleotidos y polipeptidos, en particular del virus del colera del cerdo.

Country Status (11)

Country Link
EP (1) EP0479866B2 (es)
JP (1) JP3262273B2 (es)
KR (1) KR0183368B1 (es)
AT (1) ATE191504T1 (es)
AU (1) AU5955190A (es)
DE (1) DE69033503T3 (es)
ES (1) ES2146574T5 (es)
HU (1) HU220237B (es)
NL (1) NL8901651A (es)
RO (1) RO114347B1 (es)
WO (1) WO1991000352A1 (es)

Families Citing this family (7)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5811103A (en) * 1989-03-19 1998-09-22 Akzo Nobel N.V. Hog cholera virus vaccine and diagnostic
ZA901719B (en) * 1989-03-19 1991-01-30 Akzo Nv Hog cholera virus vaccine and diagnostics
US5935582A (en) * 1990-03-16 1999-08-10 Akzo Nobel, N.V. Hog cholera virus vaccine and diagnostic
US5731167A (en) * 1992-01-17 1998-03-24 The United States Of America As Represented By The Department Of Health And Human Services Autotaxin: motility stimulating protein useful in cancer diagnosis and therapy
CN100516221C (zh) * 1994-06-17 2009-07-22 动物保健研究所 突变体猪瘟病毒株的核苷酸序列,由这些序列编码的多肽及它们的应用
FR2751224B1 (fr) * 1996-07-19 1998-11-20 Rhone Merieux Formule de vaccin polynucleotidique contre les pathologies respiratoires et de reproduction des porcs
US8063195B2 (en) * 2009-05-22 2011-11-22 The United States Of America As Represented By The Secretary Of Agriculture Mutations in a toll-like receptor motif in the NS4B of classical swine fever virus strain brescia influences virulence in swine

Family Cites Families (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
ZA864879B (en) * 1985-07-08 1987-03-25 Wallone Region Vaccines and diagnostics derived from boving diarrhoea virus
IE870507L (en) * 1986-03-07 1987-09-07 Biothechnological Res Partners Bovine virus diarrhea and hog cholera vaccines
EP0354213A1 (en) * 1987-03-09 1990-02-14 The Upjohn Company Transgenic animal cells resistant to viral infection
ZA901719B (en) * 1989-03-19 1991-01-30 Akzo Nv Hog cholera virus vaccine and diagnostics

Also Published As

Publication number Publication date
NL8901651A (nl) 1991-01-16
HU906667D0 (en) 1992-06-29
EP0479866A1 (en) 1992-04-15
DE69033503T3 (de) 2006-07-27
EP0479866B2 (en) 2005-05-25
HUT63194A (en) 1993-07-28
AU5955190A (en) 1991-01-17
JP3262273B2 (ja) 2002-03-04
ES2146574T5 (es) 2005-10-16
KR0183368B1 (ko) 1999-04-01
KR920702720A (ko) 1992-10-06
DE69033503T2 (de) 2000-08-24
JPH04506453A (ja) 1992-11-12
HU220237B (hu) 2001-11-28
DE69033503D1 (de) 2000-05-11
EP0479866B1 (en) 2000-04-05
ATE191504T1 (de) 2000-04-15
RO114347B1 (ro) 1999-03-30
WO1991000352A1 (en) 1991-01-10

Similar Documents

Publication Publication Date Title
DE69206631D1 (de) Impfstoff gegen das Fortpflanzungs- und Atmungssyndrom bei Schweinen (PRRS) und Diagnose.
ATE233101T1 (de) Polynukleotide vakzine gegen den papilloma virus
Suradhat et al. The influence of maternal immunity on the efficacy of a classical swine fever vaccine against classical swine fever virus, genogroup 2.2, infection
HUP9903822A2 (hu) Polinukleotid-vakcinakészítmény sertések szaporodásbiológiai és légzőszervi kórképei ellen
CY1115749T1 (el) Κυκλοϊος χοιρων, νουκλεϊνικα οξεα, πολυπεπτιδια και εμβολια
UA27788C2 (uk) Композиція, що містить виділений фактор лелістада, вакцинна композиція для вакцинації тварин (варіанти), діагностичний набір для виявлення антитіла
ES2143507T3 (es) Vacunas contra la enfermedad de aujeszky y de otras enfermedades animales que contienen mutantes del virus de la pseudorrabia.
RU93058614A (ru) Мутант вируса герпеса, композиции, диагностические наборы, способы определения инфекции
Andrew et al. Protection of pigs against classical swine fever with DNA-delivered gp55
Biront et al. Inhibition of virus replication in the tonsils of pigs previously vaccinated with a Chinese strain vaccine and challenged oronasally with a virulent strain of classical swine fever virus
EA200100302A1 (ru) Способы и композиции для протективной и терапевтической генетической иммунизации
BR9202024A (pt) Virus de apivox recombinante,cultura de celulas eucariotica infectadas por um virus de avipox,vacina,sequencia de transferencia e plasmideo
Odemuyiwa et al. An outbreak of African swine fever in Nigeria: virus isolation and molecular characterization of the VP72 gene of a first isolate from West Africa
ES2146574T3 (es) Secuencias de nucleotidos y polipeptidos, en particular del virus del colera del cerdo.
NO954135L (no) Fiskebukspyttkjertel-sykdomsvirus
KR890700030A (ko) 인플루엔자균(Haemophilus influenzae)의 백신 및 진단방법
Lawman et al. Electroporation enhances immune responses and protection induced by a bovine viral diarrhea virus DNA vaccine in newborn calves with maternal antibodies
BR0209251A (pt) Vacina contra vìrus da febre aftosa
ES2058100T3 (es) Vacuna combinada.
Totté et al. Production of alpha interferon in Cowdria ruminantium-infected cattle and its effect on infected endothelial cell cultures
Camero et al. Bubaline alphaherpesvirus 1 induces a latent/reactivable infection in goats
HUP9700975A2 (hu) Élő, legyengített, Pasteurellaceae családba tartozó, RTX-termelő baktériumok
AR012944A1 (es) Preparacion de virus de la enfermedad de marek usando lineas de celulas continuas de mamifero
ES2074965B1 (es) Virus mutante recombinante de rinotraqueitis infecciosa bovina y vacunas que lo contienen.
ES2105984A1 (es) Adenovirus recombinantes que expresan antigenos del virus de la gastroenteritis porcina transmisible (vgpt) y su empleo en la formacion de vacunas.

Legal Events

Date Code Title Description
FG2A Definitive protection

Ref document number: 479866

Country of ref document: ES